en-GBlv-LVru-RU
en-GBlv-LVru-RU

 

NEWS

 

September 17th, 2020

An article on the Epidemiology of Helicobacter pylori has been published

Helicobacter journal publishes a review article on the global distribution of Helicobacter pylori "Review: Epidemiology of Helicobacter pylori". This article summarizes the latest information on the epidemiology of Helicobacter pylori and possible types of infection.

A total of 32 publications were collected; in addition to English language publications, the authors have included original language publications from Latin America and Russia. Employees of the KPMI were contributed to the article - research assistant Linda Mežmale and leading researcher prof. Marcis Leja, in cooperation with foreign colleagues.

Link to the article abstract available HERE.

View picture

September 14th, 2020

The first serious virtual conference in gastroenterology - EHMSG 2020 - has passed 

In response to the global COVID-19 pandemic the 33rd Workshop of the European Helicobacter and Microbiota Study Group  was held in a virtually compact version on Saturday, September 12, 2020.

One of the congress symposiums "Gastric Cancer – Early detection and prevention 2020" was chaired by Mārcis Leja, Director of the KPMI.

Scientists from the KPMI also participated with E-poster presentations.

Representatives of our research team gave 6 E-poster presentations:

Linda Mežmale gave two presentations:
"Application of gold nanoparticles and metal oxide sensors for non-invasive detection of gastric cancer"
"Identification of volatile organic compounds emitted by gastric juice".

Alise Lielause gave the presentation "The comparison of side effects and effectiveness of standard triple therapy with clarithromycin and alternative high-dose amoxicillin / bismuth therapy in eradication of H.pylori".

Jeļizaveta Aleksejeva gave the presentation "H. pylori prevalence in individuals with allergic disease in the Latvian population".

Arta Deniņa gave the presentation "Comparison of glucose and lactulose breath test results for detecting small intestinal bacterial overgrowth".

Pawel Mochalski's report "In vitro profiling of volatile organic compounds released and consumed by CLS-145 and HGC-27 gastric cancer cell lines" was also presented.

The results of KPMI's largest study GISTAR, VOGAS, "Volatile organic compounds for potential application in gastric cancer screening" and other researches of the institute were reported in the form of E-poster presentations.

View picture

In the picture: LU KPMI research assistant Linda Mežmale with E-poster presentation

* VOGAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 
* GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions"
* Project "Volatile organic compounds for potential application in gastric cancer screening" is funded by FLPP (Fundamental and Applied Research Projects) Program. Program is implemented by Latvian Council of Science, project No. lzp-2018/2-0228 

September 9th, 2020

Congratulations to the newly admitted doctoral students of the University of Latvia!

We congratulate the newly admitted doctoral students of the University of Latvia, whose doctoral dissertation topics are related to KPMI.

Andrejs Pčolkins

Thesis topic "Prevention of surgical complications in colorectal cancer surgery by performing mechanical bowel preparation with non-absorbable antibiotics", supervisors - M.Leja and A.Sīviņš, branch of science - Surgery.

Ilze Enģele

Thesis topic "Identification of radiological biomarkers using contrast mammography for patients with breast cancer", supervisors - J.Eglītis and M.Leja, branch of science - Oncology / hematology.

Liene Sondore

Thesis topic "Compliance of dietary habits of the risk group population of Latvia with the recommendations of the World Health Organization and their relation to the risk of non-infectious diseases", supervisors D.Šantare and I.Daugule, branch of science - Public Health.

September 8th, 2020

Congratulations to the staff of our institute in new positions!

At the annual staff meeting held on September 4, which took place for the first time this year at the Science House of the Academic Center of the University of Latvia, the staff looked back and discussed the upcoming events in the new academic year.

Acknowledgments and thanks were presented at the meeting, as well as employees who have taken up new positions were welcomed.

Among them, the leading researcher of our institute Dr.med. Sergey Isajev has become a professor this year.

PhD Manohar Prasad Bhandari, head of the postdoctoral research project, has been elected as a leading researcher at KPMI.

Congratulations!

View picture

© Photo: Toms Grīnbergs, Department of Communication and Innovation, University of Latvia

September 7th, 2020

Invites to a webinar on the EU Health Policy Platform

Digestive Cancers Europe (DiCE) European umbrella organisation of a large group of national Members representing patients with digestive cancer invites interested parties to register for the second live webinar:

"The Financials of CRC Screening - Better Investments to Save More Lives"

 which will take place on the EU Health Policy Platform on October 7, 10:00am.

This is the second in a series of webinars as a part of the European Health Policy Platform's Thematic Network: 'Colorectal Cancer Screening in the European Union' led by Digestive Cancers Europe in partnership with the European Commission.

Please join and continue to help shape EU policy by contributing to Joint Statement on Colorectal Cancer Screening in the EU.

Register for the live Webinar HERE.

More information: www.digestivecancers.eu

View picture

September 4th, 2020

Invites to participate in the development of the Horizon Europe First Strategic Plan

We invite you to take this opportunity to follow the European Commission's call for your views on the forthcoming Horizon Europe First Strategic Plan (2021-2027) by participating in an online survey. Its results will be used to finalize the strategic plan and clarify the impact logic that will guide the future work programs of Horizon Europe.

The survey is available on the EUSurvery portal, the submission deadline is September 18.

We invite you to be active and use this opportunity!

View picture

August 27st, 2020

Get involved in beating cancer, because cancer affects us all! Citizens are invited to express their opinion!

Healthy people want to stay healthy, patients and their families fighting cancer benefit from better therapy, cancer patients expect a better quality of life after treatment, and better support for carers is needed. Health and well-being are the concern of us all. 

Your opinion is important - say it! What is relevant for you? Which actions do you think are most important in the fight against cancer? Your feedback board will use it to adjust the plan. Let's join forces, because together we will beat cancer better!

The following measures are therefore envisaged:

1) On August 28, joined the conversation organized by the Cancer Mission Council on Twitter

 #MissionCancer #EUmissions #HorizonEU.

2) Citizens will be able to submit proposals to the webpage from 31/08 to 04/09 
https://getinvolvedinmissions.eu/conferences/cancer/f/113/

3) The details of the event in Latvia will appear here:

https://getinvolvedinmissions.eu/assemblies/cancerlv

Read more about the activities of the European Commission's Cancer Mission HERE

View picture

 

August 21st, 2020

 

Today there will be a public discussion "Relevance of European Cancer Mission recommendations for cancer patients in Latvia"

Today, August 21, at 16.00 Cancer patients and their organizations, doctors, politicians and other interested parties will take part in the discussion with the aim to identify current problems for Latvian cancer patients in the context of the 13 recommendations for combating cancer developed by the European Cancer Mission Council. It will be possible to participate in the discussion remotely, and a representative of the Council of the European Cancer Mission, Director of the LU KPMI, Professor Mārcis Leja will make a presentation.

The event will be opened a representative of the management of the University of Latvia, as well as the acting head of the European Commission Representation in Latvia Andris Kužnieks. This will be followed by a presentation by Professor Mārcis Leja, a representative of the European Cancer Mission Council and the Director of the LU KPMI, in which special attention will be paid to the most important recommendations developed by the European Cancer Mission Council for Latvian cancer patients. Harijs Gals, founder of the Association of Lung Cancer Patients and Relatives, founder of the organization "Onaliance" will share his opinion, and Olga Valcina, founder of the organization "On the Front of Melanoma", founder of the organization "Onaliance", will give a presentation. At the end of the first part of the event, Evita Zālīte-Grosa, the head of the group of deputies for oncology patient support, a member of the Social and Labor Affairs Committee of the Saeima and a deputy of the 13th Saeima of the Republic of Latvia, will express her opinion.

In the second part of the event, both face-to-face and remote participants will participate in the discussion. The expressed opinions and expressed positions will allow to define the most important tasks for the promotion of the protection of the interests of Latvian cancer patients at the local and European Union level. The findings and conclusions of the discussion will serve as a basis for the development and transmission of a document confirming the common position to the Ministry of Health of the Republic of Latvia and the European Commission. "In order to find long-term and sustainable solutions, it is necessary to promote joint dialogue and feedback with Latvian cancer patients and organizations representing their interests," emphasizes Professor Mārcis Leja, a representative of the Council of the European Cancer Mission and the director of the LU KPMI.

On August 21 from from 16.00 to 19.00 we invite media representatives and everyone interested to a public discussion dedicated to the European Cancer Mission:

in person, in the main building of the University of Latvia, Great Hall, 19 Raina Boulevard, Riga

or by registering for remote participation in the ZOOM platform: https://ej.uz/vezadiskusija and watching the live broadcast on the website of the University of Latvia https://ej.uz/vezadiskusija_tiesraide or on the Facebook page of the University of Latvia https://www.facebook.com/latvijasuniversitate/

The discussion is organized by the University of Latvia in cooperation with the European Commission Representation in Latvia. The Institute of Clinical and Preventive Medicine of the University of Latvia invites to the event.

August 20th, 2020

"Morning Panorama"  - LU KPMI director, representative of the of the Council of the European Cancer Mission

In anticipation of the public discussion "Relevance of European Cancer Mission recommendations for cancer patients in Latvia" on August 20, the University of Latvia has invited the director of KPMI, the representative of the Council of the European Cancer Mission Council Marcis Leja.

DISCUSSION "Relevance of European Cancer Mission recommendations for cancer patients in Latvia"
WHEN? August 21 at 16:00
WHERE? University of Latvia (LU), Great Hall

WHO ORGANIZES?

European Commission Representation in Latvia

University of Latvia

INVITES - Institute of Clinical and Preventive Medicine

SUPPORT - SIA Roche Latvija

INFORMATIC SUPPORTER - SIA "Divi gani sabiedriskās attiecības" 

OBJECTIVE OF THE MEASURE - to identify current problems of Latvian cancer patients and to discuss the 13 recommendations for combating cancer developed by the Council of the European Cancer Mission.

The interview with M.Leja can be viewed HERE.

View picture

August 18th, 2020

The Latvian competition of the EEA and NFI Baltic Research Program will be announced

The forthcoming Latvian competition of the Baltic Research Program is planned to be announced on August 19, 2020 and project applications will be able to be submitted in five different topics. Information about the competition and documents will be published on the European Economic Area and Norwegian grant website.

The Baltic Research Program is one of the activities of the European Economic Area (EEA) and the Norwegian Financial Mechanism (NFI) Program “Research and Education”, which strengthens Baltic research co-operation.
                           
The State Education Development Agency and the Latvian Ministry of Education and Science invite scientists, applicants for scientific degrees, doctoral students and cooperation project managers from scientific institutions in Latvia, Norway, Iceland, Liechtenstein, Estonia, Lithuania, as well as other countries to participate in the European Economic Area and Norwegian Financial Mechanism to participate in "Baltic Research Programs" Latvian competition opening event online (ZOOM) on August 26 at 10:00 - 13:00.

Registration for the seminar until August 21 by filling in the application is available HERE.

Event program available HERE.

More information - HERE.

View picture

August 17th, 2020

Deadline for submission of Marie Skłodowska-Curie scholarship competition projects - September 9!

Project applications are invited by 9 September 2020 for calls for proposals under the MSCA's Individual Fellowships sub-program, including the Horizon Sklodowska-Curie Individual Fellowship Call for the Horizon 2020 sub-program of the Horizon 2020 research and innovation support program.

They provide individual mobility grants of 12-36 months for the most promising experienced researchers of any nationality and age for employment in the Member States of the European Union or in the countries associated with Horizon 2020. IF project applications are prepared by researchers in collaboration with the host organization, without thematic restrictions. Each researcher may submit only one application to the competition, but host organizations may admit more than one researcher.

On August 18, 2020 the Horizon 2020 National Contact Point will hold an online seminar on the Open Skills Individual Fellowships for the Horizon 2020 Marie Skłodowska Curie Actions (MSCA). The online seminar will tell project applicants about the conditions of participation and the project application process.

The webinar will inform project applicants about the Individual Scholarship in the latest Horizon 2020 project competition. Participants will be introduced to the conditions of participation, as well as provide practical information on how to submit project applications on the Funding & Tenders portal.

The webinar will take place on the online platform Zoom at 13:00 - 14:30 and can be registered online until 17 August, 12.00.

A guide for project applicants and 11 steps to a successful project.

View picture

August 14th, 2020

A public debate on the European Cancer Mission will be held

On August 21, the University of Latvia (UL) and the European Commission Representation in Latvia are organizing a public discussion dedicated to the European Cancer Mission. Its aim is to identify current problems for Latvian cancer patients and to discuss the 13 recommendations for beating cancer developed by the Council of the European Cancer Mission. Cancer patients and their organizations, doctors, politicians and other stakeholders are invited to participate.

The discussion will serve as a platform for the exchange of views, promoting dialogue between all parties involved and allowing to set the main tasks for the promotion of the interests of Latvian cancer patients at the local and European Union level. Participation in the discussion will allow everyone present to share their experiences, express their views and be heard. After that, a written document confirming the common position of Latvian cancer patients' organizations will be sent to both the Ministry of Health of the Republic of Latvia and the European Commission. Thus, significant steps will be taken in promoting public health and defending the interests of Latvian cancer patients at both the national and international levels. The European Cancer Mission is one of five European research and innovation missions and is part of the Horizon Europe Framework Program, which will be launched in 2021.

The event will be opened by the Rector of the University of Latvia Indriķis Muižnieks and the Acting Head of the European Commission Representation Andris Kužnieks. The part of the discussion will be introduced by the presentation of the Director of the Institute of Clinical and Preventive Medicine of the University of Latvia and the representative of Latvia in the Council of the European Cancer Mission, Professor Mārcis Leja, with special emphasis on recommendations for Latvian cancer patients. "Several of the recommendations made by the Council of the European Cancer Mission concern the protection of patients' interests. In the Latvian context, it is important to ensure and promote equality among all patients. This can be achieved by improving screening programs, as well as by establishing accredited cancer centers in Latvia. However, the main goal of the discussion is to get feedback from Latvian cancer patients' organizations and inform the European Commission about the most significant findings”, explains Mārcis Leja, a representative of the Council of the European Cancer Mission and Professor of the University of Latvia.

The discussion will take place on August 21 in the main building of the University of Latvia, in the Great Hall, 19 Raina Boulevard, from 16:00 - 19:00. It will also be possible to join remotely, a link will be sent to registered participants by e-mail shortly before the event.

You can apply for the discussion in person or remotely here: https://ej.uz/vezadiskusija

The discussion is organized by the University of Latvia in cooperation with the European Commission Representation in Latvia. The Institute of Clinical and Preventive Medicine of the University of Latvia invites to the event.

View picture

 

August 4th, 2020

The latest news on the activities of the European Commission's Cancer Mission

In September 2019, the Science and Innovation (R&I) Day is takeing place in Brussels. During these days, the European Commission (EC) also officially launched a new form of action - mission-based science, already known in other parts of the world, but first introduced at European Union level.
The importance of missions is to bring science into a way that is understandable, usable and recognizable to the public.
A total of five missions have been set up to address the EC's identified hot topics - Clean Cities, Clean Oceans, Clean Environment and Nutrition, Adaptation to Climate Change and the Cancer Mission. The latter is represented by Professor Marcis Leja, Director of the Institute of Clinical and Preventive Medicine, University of Latvia.

In December 2019, the the second meeting of the Cancer Mission set up by the European Commission with representatives of EU Member States takes place in Brussels.

In January 2020 in in Brussels Oncology Meeting outlined the new EU Beating Cancer Plan and gaved a brief overview of the activities of the EU Cancer Mission.

In February 2020, The first joint meeting of the EC Cancer Mission Council and the Assembly of this mission took place in Brussels, to discuss actions to be taken in the strategic planning documents.

Cancer affects everyone regardless of age, gender or social status and represents a tremendous burden for patients, families, and societies at large. By joining efforts across Europe, more people would live without cancer, more cancer patients would be diagnosed earlier, would suffer less and have a better quality of life after treatment.

Partly inspired by the Apollo 11 mission to put a man on the moon, the European research and innovation missions aim to deliver solutions to some of the greatest challenges facing our world. 

More information:  https://ec.europa.eu/mission-cancer #EUmissions #MissionCancer

Cancer Mission video is now on-line on Youtube.

 

August 3rd, 2020

The results of the LZP-funded project have been published in an internationally cited ethics journal

Based on the results of a public survey conducted within the project “Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers” funded by the Latvian Science Council, LU KPMI and Latvian Biomedical Research and Study Center (BMC) researchers have published an article in the journal "BMC Medical Ethics".

Research biobanks are collections of human biological samples (eg blood, tissue, urine samples).

The aim of the survey was to find out the public's awareness and attitude towards research biobanks in Latvia, repeating the questions asked in the 2010 Eurobarometer survey.

Public awareness of research biobanks is important for the development and sustainability of biobanks.

Read full information about the published article HERE.

Link to the article HERE

 
In the picture: the author of the article, the leading researcher of LU KPMI Signe Mežinska

The work was supported by FLPP (Fundamental and Applied Research Projects) Programm in Latvia, project nr. lzp-2018/2-0171 "Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers"

July 31st, 2020

Topicalities of the project “Investigation of the relationship between gastric microbiome and volatile organic compounds for early diagnosis of gastric cancer” in the second quarter of 2020

On May 1, 2020, leading researcher, Manohar Prasad Bhandari (PhD in Information Engineering), started the work at LU KPMI, implementing the postdoctoral research project "Investigation of the relationship between gastric microbiome and volatile organic compounds for early diagnosis of gastric cancer".

In the period from 01.05.2020. until 31.07.2020., within the framework of the project, a literature analysis on the latest research on volatile organic compounds (VOCs) from the gastric microbiota, gastric tissues (products of cancer cell metabolism) and exhaled breath for an early detection of gastric cancer was performed. The scientific activities and tasks to be performed were determined, adapting the plan to the current situation in the conditions of limited mobility. The collection of samples for the GC-MS based analysis has already started.

Read more about this project activities HERE.

   

The project is funded by the ERDF (European Regional Development Fund) within the framework of the measure  1.1.1.2. "Postdoctoral Research Support" Round 3 ", Project ID Nr.1.1.1.2/VIAA/3/19/495 "Investigation of the relationship between gastric microbiome and volatile organic compounds for early diagnosis of gastric cancer"

July 14th, 2020

Clinical validation study is being implemented in the project "Volatile Marker Breath Analyzer for Gastric Cancer Screening"

Following the successful validation of portable express analyzer devices, a clinical validation study was initiated. This study included patients with a confirmed diagnosis of gastric cancer, patients with high-risk changes, and control patients with a known condition of the gastric mucosa.

The main goal is to validate clinical sensors by developing a model that will be able to distinguish the studied changes from the control measurements, and to further use this model in individuals with well-defined gastric changes.

The implementation of the project was significantly affected by the WHO statement of 11 March 2020 on the COVID-19 pandemic. An emergency situation was declared throughout the territory of Latvia until June 9, 2020 with the aim to limit the spread of COVID-19. To protect patients and physicians from possible COVID-19 infection, patient recruitment for the project was partially restricted until the end of the emergency. In the second half of June, restrictions on health care services in both public and private medical institutions were lifted and patient recruitment has actively resumed.

 

The project is funded by the ERDF (European Regional Development Fund) within the framework of the measure 1.2.1.2. "Support for the Development of Technology Transfer System", Project ID Nr. KC-PI-2017/75 "Volatile Marker Breath Analyzer for Gastric Cancer Screening"

July 2nd, 2020

The GISTAR study is written about and shown on TV

We invite to get acquainted with the latest information about the largest study of LU KPMI - GISTAR written in Jēkabpils media and shown on TV.
Article in the information portal "Jēkabpils Laiks".
The television story of Vidusdaugava's TV​.

   

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions"

June 30th, 2020

Anticipates a significant impact of the latest recommendations of the EU Mission for Cancer Report on improving the organization of the oncology industry in Latvia

European Commission has published the Interim Report of the EU Mission for Cancer containing altogether 13 Recommendations for Conquering Cancer in the EU. Establishment of comprehensive cancer infrastructure in each of the Member States, assuring the access to qualitative cancer screening, digital transformation, improved collaboration within and across the Member States are some of the key recommendations of this document.

The recommendations are expected to have an important role also for Latvia. 

The recommendations have been supported by experts (including from Mission for Cancer Assembly) and politicians.

Currently the text is presented to stakeholders in the EU Member States before submitting the final version to the Commission.

More information on the EU Mission for Cancer Report: HERE

June 25th, 2020

ESDO news - the latest information on ESDO educational activities

European Society for Digestive Oncology informs about the planned educational activities::

• ESDO Masterclass in Berlin, November 6-7, 2020:

www.esdo.eu/education/esdo-master-class

• New slide decks from ASCO virtual symposium:

www.esdo.eu/publications/gi-slide-decks

June 19th, 2020

TEAM OF KPMI WISHES JOYFUL LĪGO DAY AND ST.JOHN'S DAY!  

June 10th, 2020

Students of Riga Stradins University defend their final theses - based on additional research of the GISTAR project

At Riga Stradins University, two students have defended their diploma theses, whose research is based on additional research of our institute's largest research GISTAR.

Ilze Indriksone-Gromova, a master's student of the Faculty of Public Health and Social Welfare program "Nutrition Science", conducted a study "Influence of Mediterranean eating habits on risk factors for cardiovascular disease in Jēkabpils population", while Rehabilitation faculty study program "Nutrition" bachelor's thesis defended Lelde Cīrule with her work “Evaluation of the compliance of the eating habits of the participants of the GISTAR project Jēkabpils with the Nordic diet”.

The students' research was led by the leading researcher of the institute Dr.med Daiga Šantare.

Dr.sc.ing. Inese Poļaka, the leading researcher of the institute, advised on the analysis of the research data. 

 

June 10th, 2020

Highlights of the "Information and Communication Technology Competence Center" project in the second quarter of 2020

IT Center of Competence pursuant to Contract Nr. 1.2.1.1/18/A/003 of May 9, 2019 with the Central Finance and Contracting Agency  is implementing the project "Information and Communication Technology Competence Center".

In the second quarter of 2020, the project continues the implementation of all initially approved studies and launches two new research projects. The fourth request for payment has been prepared and submitted, and meetings of both the heads of scientific directions and the council are held regularly, where the progress of the implemented research and the achieved results are reviewed. In the emergency situation regarding the spread of Covid-19 due to national restrictions, all meetings took place remotely. Remote work and canceled measures have in some cases led to changes in the timing of research, but in general the implementation of research has not been significantly affected.

Highlights of the implemented researches:
• SIA “Datorzinību centrs” and University of Latvia research No. 1.5 “Development of a research support model to improve the medical research data collection process” started in May 2019. In the first quarter of 2020, the implementation of two industrial research activities will continue - “Development of the Research Support Model” and “Development of the Concept of Technological Implementation of the Research Support Model”.

The project is co-financed by the European Regional Development Fund Operational Program "Growth and Jobs" 1.2.1. Specific objective 1.2.1.1 of the Specific objective "Increase private sector investment in R&D". the measure "Support for the development of new products and technologies within centers of competence"

June 9th, 2020

GISTAR project - among FLPP funded projects

We are proud that among the projects financed in the 1st competition of the Fundamental and Applied Research Projects of the Latvian Council of Science in 2018 in the field of Medical and Health Sciences, also is the project GISTAR implemented by LU KPMI!

More information - HERE

The GISTAR study is funded by FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

June 4th, 2020

Doctoral students of the Faculty of Computer Science will present at the seminar of the doctoral school

Doctoral students of the Faculty of Computer Science of the University of Latvia will present their topics at the next seminar of the Doctoral School "Translational research in medicine":
1. Maxim Ivanov with the topic "From neuronal morphology to sensorimotor integration: why to study the rat brain"
2. Aleksandrs Levinskis with the topic "Application of Kalman filter for sensor data processing"
The seminar will be held online, via https://meet.google.com/!

Please send your application to participate in the seminar in time to our school's e-mail (doktoranturas.skola@gmail.com) or by sending a letter on the Facebook page (https://www.facebook.com/Doktoranturas.skola/)

Every participant who applies for participation will receive an invitation link to meet.google.com in their e-mail on the day of the seminar (10 minutes before), where they can join the seminar online.

The seminar will take place on 11.06. 16:15 - 17:45.

Facebook page of the seminar - HERE.

May 29th, 2020

The latest newsletter of the PERSIST project has been published

Lead by Gradiant, Spanish ICT technology center in collaboration with the University of Latvia and eleven other partners, PERSIST was started in January 2020. 

The PERSIST project combine the expertise of its partners to develop an innovative platform that support the decision-making of medical doctors to improve the care of cancer survivors.

13 entities from 10 countries participate in this international research based on Artificial Intelligence and Big Data for the health industry.

The consortium, with partners from Spain, Italy, Austria, Bulgaria, Slovenia, Latvia, Switzerland, Portugal, Belgium and Turkey, is funded by the European Union with more than 5 million euros, under the Horizon 2020 program. 

Within the framework of the PERSIST project, Institute of Clinical and Preventive Medicine of the University of Latvia provide clinical research.

The May newsletter of the PERSIST project - HERE.

   

Project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

May 21st, 2020

Our students defend their diploma theses at the University of Latvia with an excellent grade

At the Faculty of Medicine of the University of Latvia, our students Alise Lielause and Arta Deniņa have defended their diploma theses with excellent marks in the Treatment program.
Both students are prospective doctors.
The topic of Alice Lielause's work "The comparison of side effects of standard triple therapy with clarithromycin and alternative high-dose amoxicillin and bismuth therapy in eradication of Helicobacter pylori", Artas Deniņa's work topic - "Detection of small intestinal bacterial colonization by exhalation test - comparison of glucose and lactulose tests".
The scientific supervisor of both works is Professor Marcis Leja, the director of our Institute.
Congratulations to both girls!

May 20th, 2020

EHMSG 2020 goes virtual

In response to the global COVID-19 pandemic, it has been decided that the 33rd Workshop of the European Helicobacter and Microbiota Study Group (originally scheduled to take place from September 10 – 12, 2020 in Glasgow, United Kingdom) will take place as a virtual conference in a compact version, on one day only - Saturday, September 12, 2020.

Both live and on demand talks as well as a platform for -Posters will be provided.

Abstract Submission has been extended until June 21, 2020 at 24.00hrs CET.
You can submit your e-Poster for presentation at the conference HERE.

Proper tools that allow similar elements of connectivity and involvement for all participants will be provided.

To guarantee the health and safety of our attendees, speakers, exhibitors, sponsors and staff, the EHMSG Board has come to the conclusion that the conference cannot take place in its scheduled format this year.

In case of any questions please do not hesitate to contact by emailing: workshop@ehmsg.org.

More information about EHMSG 2020: https://www.workshop.ehmsg.org/.

May 18th, 2020

Topics prepared by doctoral students: Ist seminar

Doctoral students of the Faculty of Medicine of the University of Latvia will present their topics at the next seminar of the Doctoral School "Translational research in medicine":
• dr. Tatjana Zablocka - "Development of a new clinical genomic technology for melanoma risk stratification, prognosis assessment and personalized therapy";
• dr. Lauris Repša - "Strategies for the treatment of hip arthroplasty infection";
• dr. Māris Mežeckis - "The role of radiosurgery in the treatment of moderate and high-risk prostate cancer".
The seminar will be held online, via https://meet.google.com/!

Please send your application to participate in the seminar in time to our school's e-mail (doktoranturas.skola@gmail.com) or by sending a letter on the Facebook page (https://www.facebook.com/Doktoranturas.skola/)

Every participant who applies to participate will receive an invitation link to meet.google.com in their e-mail on the day of the seminar (10 minutes before), where they can join the seminar online.

The seminar will take place on May 28th, 16:15 - 17:30.

May 11th, 2020

Invites to the seminar of the Doctoral School "Translational research in medicine" "Preparation of a manuscript for publication in a scientific journal"

This time the seminar will be led by the Chairwoman of the Doctoral School "Translation research in medicine", University of Latvia, Faculty of Medicine, Assoc. prof. Ilva Daugule.
The seminar will be held online, via https://meet.google.com/!

Please send your application to participate in the seminar in time
to our school e-mail - doktoranturas.skola@gmail.com
or by sending a letter on the Facebook page - https://www.facebook.com/Doktoranturas.skola/

Every participant who applies for participation on the day of the seminar (5-10 minutes before) will receive an invitation link to meet.google.com in their e-mail, where they can join the seminar online.

The seminar will take place on May 14th, 16:15 - 17:30.

April 20th, 2020

Deadline for submission of abstracts to the UEG Week Amsterdam 2020 - extendedv to May 15!

The United European Gastroenterology Week will take place on October 10 - 14  in Amsterdam, the Netherlands.

In response to the current unprecedented circumstances, the deadline for abstract submissions has been extended to 15 May!
New abstract topic: COVID-19 and GI!

UEG Week is the main platform for researchers around the world to present their latest discoveries.

UEG Week combines world class scientific research, invited lectures by leading minds in gastroenterology and an excellent Postgraduate Teaching Programme. Multidisciplinarity is a key focus of UEG Week, which covers topics of interest for the entire GI community.

More information about the conference: HERE.

April 16th, 2020

A series of remote seminars are offered by the medical information resource ClinicalKey​

The Medical Information Resource ClinicalKey offers a series of remote seminars to demonstrate the information available in the resource about CoVid-19, as well as to practice the ClinicalKey tools.

Scheduled seminars and registration:
- Tuesday, April 21 at 13.00 
- Wednesday, April 22 at 15.00 
- Thursday, April 30 at 12.00 

After registration, each participant will receive a confirmation email and a seminar access link.

Duration of seminars - about 30 min.

Working language - English.

April 14th, 2020

We invite you to actively submit your thesis to the Workshop of the Helicobacter and Microbiota Study Group!

It is not yet known in what format this year's XXXIIInd International Workshop of the Helicobacter and Microbiota Study Group will take place, scheduled for September in Glasgow, Scotland (was scheduled for September 10-12) .

However, the abstracts of the reports are accepted regardless of the form of the conference.

Deadline for submission of theses - May 10.

More information HERE.

April 9th, 2020

7 project applications have been submitted to the LZP open competition from KPMI

On January 27, The Latvian Council of Science (LZP) announced an application for the 2020 open competition of Fundamental and applied research projects (FLPP), for which the available funding is 13,510,977 euros.

7 project applications in specific fields have been submitted for this competition from the Institute of Clinical and Preventive Medicine of the University of Latvia.

Of the seven submitted project applications, 3 are in cooperation with the Latvian Biomedical Research and Study Center.

The aim of basic and applied research projects is to create new knowledge and technological insights in all fields of science. FLPP also promotes the involvement of students and doctoral candidates, the linking of research and the study environment, and the capacity building of scientific institutions and scientists. An important task is to link the results of the projects with the priority directions of science and to increase the socio-economic impact of the projects. A transparent system of reporting and financial use is also being developed, which will also allow assessing the sustainability of project results, while reducing administrative burdens and promoting inter-institutional cooperation.

Project implementation period is 3 years.

April 2nd, 2020

Wins 2nd place in RSU Student Scientific Conference 

Darija Logvinova, student of Faculty of Medicine of RSU won the second place with her work at the Annual Riga Stradiņš University (RSU) student scientific conference Health and Social Sciences, which took place on March 27 and 28, 2020.

The title of D.Loginova's presentation is "Symptoms and the time to diagnosis in patients with gastric and esophageal cancers".

The scientific leaders of D.Loginova's research are the leading researcher of LU KPMI Prof. Marcis Leja and researcher Dr. Evita Gašenko.

Over the past years, the conference has grown into the largest scientific event of its kind in the Baltics, and last year the conference's 17 thematic sections, guest lectures and practical workshops brought together more than 2,000 participants from Latvian and foreign universities.

March 31st, 2020

LU signs a contract for the supply of volatile marker breath analyzers

On March 9, the University of Latvia signed a contract with the German technology company JLM Innovation GmbH to acquire a portable exppress-analyzer for the project "Volatile Marker Breath Analyzer for Gastric Cancer Screening".
On March 23, the units was shipped and installed.

Validation of portable express-analyzer devices will be implemented in the near future, involving students of the Medical Faculty of the University of Latvia and resident physicians of Riga East University Hospital. Successful implementation of the activity will help to evaluate the repeatability and interchangeability of all devices to enable further clinical validation study of the project.

 

The project is funded by the ERDF (European Regional Development Fund) within the framework of the measure 1.2.1.2. "Support for the Development of Technology Transfer System", Project ID Nr. KC-PI-2017/75 "Volatile Marker Breath Analyzer for Gastric Cancer Screening"

March 30th, 2020

The future work of the project is discussed

On March 23, a teleconference of participants of the project "Volatile organic compounds for potential application in gastric cancer screening" was held to discuss the follow-up of a project currently affected by the announced national emergency on the new coronavirus COVID-19 infection. Decisions were also taken during the teleconference to disseminate the results of the present conference at international conferences to be held in autumn 2020:

1) United European Gastroenterology Week 2020, Amsterdam, The Netherlands.

Abstracts can be submitted until April 24.

2) 33rd Workshop of the European Helicobacter and Microbiota Study Group, Glasgow, United Kingdom.

Abstracts can be submitted until May 10th.


The work was supported by FLPP (Fundamental and Applied Research Projects) Programm in Latvia, project nr. LZP2018/29 "Volatile organic compounds for potential application in gastric cancer screening"

March 26th, 2020

The first issue of the University Therapeutic Journal has come out

The first issue of the scientific and practical journal University Therapeutic Journal ("St. Petersburg") has been published.

The journal will combine the efforts of professionals from various disciplines to address the scientific and practical issues of modern health care in the field of Internal Diseases and related areas.

The journal covers a wide range of therapeutic specialties, including pediatrics, cardiology, pulmonology, gastroenterology, geriatrics and more. The multidisciplinary approach to compiling the scientific and practical section of the journal will not leave aside specialties such as surgery, endoscopy, microbiology and experimental medicine.

M. Leja, Director of the LU KPMI, also is on the editorial board of the magazine.

The contents of the first issue of the magazine are available HERE.

More information HERE.

March 24rd, 2020

March 24 - World Tuberculosis Day

Also in the days where media attention is focused on Covid-19 outbreak, TB is an always present threat.

World TB day, which is set every 24th march,  is thought to raise public attention to this disease.

Within the framework of the PITBUL project, in cooperation with the partner GNA Biosolutions GmbH, a German molecular diagnostic company, we also want to raise public awareness of the disease.

More information HERE.

    

The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 768889

March 23rd, 2020

Highlights of the "Information and Communication Technology Competence Center" project in the first quarter of 2020

IT Center of Competence pursuant to Contract Nr. 1.2.1.1/18/A/003 of May 9, 2019 with the Central Finance and Contracting Agency  is implementing the project "Information and Communication Technology Competence Center".

In 2020, the project continues the implementation of all initially approved studies, prepares and submits a third payment request, and holds regular meetings of both the Scientific Leaders and the Council to review the progress and results of the implemented research. In turn, from the selection of new research projects announced in the summer of 2019, three new research projects have been approved by ABC Software Ltd. with SEB Bank support, WeAreDots Ltd. and LASMA Limited Liability Company with Altas IT Ltd. support, SIA Dati Group, as well as one new project application submitted for approval by SIA Captomatic.

“Computer Science Center” Ltd. and University of Latvia research Nr. 1.5 "Development of a Research Support Model to Improve Medical Research Data Collection Process" launched in May 2019. In the first quarter of 2020, the implementation of two industrial research activities - “Development of a Research Support Model” and “Development of a Technology Support Concept for a Research Support Model” - will continue.

The project is co-financed by the European Regional Development Fund Operational Program "Growth and Jobs" 1.2.1. Specific objective 1.2.1.1 of the Specific objective "Increase private sector investment in R&D". the measure "Support for the development of new products and technologies within centers of competence".

More information read HERE.

March 13th, 2020

International Scientific Medical Conference of the University of Latvia postponed to autumn

In view of the current epidemiological situation in the world, the management of the University of Latvia and the Conference Organizing Committee, in consultation with the SPKC (Center for Disease Prevention and Control), have decided to postpone the International Scientific Medical Conference to October of this year.

The conference organizers will keep informed potential participants and interested parties about the news and current events.

March 13th, 2020

Workshop on "Ethically and socially responsible governance of research biobanks in the Baltic states" is canceled

In view of the rapid spread of COVID-19 infection, and in order to reduce the risk of infection with it workshop organizers, participants and guests, a decision was made to cancel the March 19 workshop "Ethically and socially responsible governance of research biobanks in the Baltic states" (was organized within the framework of the 78th International Scientific Conference of the University of Latvia).

The workshop may be postponed to the end of the summer, but the date is still to be determined. Organizers of the workshop will keep informed potential articipants.

The decision is made because the government of Latvia has declared a state of emergency to limit the spread of COVID-19 virus.

March 13th, 2020

On significant restrictions in relation to COVID-19

In order to minimize the risks of COVID-19 infection for staff, students, guests and visitors of the University of Latvia, the on-site study process is discontinued between March 13 and April 14.

During the period 13.03.2020. until 4.14.2020.LU implements the following epidemiological safety measures to limit the spread of COVID 19:

* to discontinue the implementation of face-to-face lectures, classes, seminars and other forms of face-to-face, continuing education and interest education
* stop organizing conferences and any other face-to-face events (with more than 100 participants) in the LU
* to organize the study process remotely using LU e-learning environment, including video etc. possible formats
* LU core departments, including scientific institutes and LU administration, should work remotely as far as possible
* LU students are allowed access to LU premises (libraries) upon presentation of a valid LU student card

LU staff, including students, are strongly encouraged to follow the recommendations of the Center for Disease Prevention and Control (https://spkc.gov.lv/en/aktualitates/get/nid/757), especially when returning from business trips or vacation trips.

The decision is made because the Latvian government has declared a state of emergency to limit the spread of the COVID-19 virus.

We encourage you to follow the LU management orders, instructions, action recommendations regarding information on security measures at the LU homepage.

March 12th, 2020

A video produced jointly by H2020 project SNIFFPHONE partners has been published online 

SNIFFPHONE (Horizon 2020 Framework Program) project carried out by an international consortium of scientific institutions and companies (also a member was LU KPMI) - "Smart Phone for Disease Detection from Exhaled Breath", in which the clinical work was organized and conducted by researchers of the Institute of Clinical and Preventive Medicine was carried out 15.02.2015. – 15.08.2018.

The SNIFFPHONE project has developed a cellular-compatible sensor respiratory analyzer for detecting diseases - a portable "electronic nose" capable of accurately identifying gastric cancer after a patient's exhalation. The device has a very wide potential application and can be transferred to other disease detection and monitoring.

Sniffphone developers are engineers and scientists from Israel, Germany, Ireland, Austria and Finland.

The University of Latvia has been a major clinical partner in this major project to develop new disease screening techniques using artificial nose technology.
LU KPMI project implemented device testing in clinical settings, analytics, patient involvement, sensor data analysis.

The project was led by professor Hossam Haick from the Israeli Technion Institute.
The head of the clinical team of the project is M.Leja, Director of the LU KPMI.

The SNIFFPHONE project has also received the European Commission Innovation Award in the Innovative Project category. The award was presented on November 21, 2018 in Lisbon, Portugal, at the European Forum on Electronic Components and Systems.

Researchers of the Institute are continuing their research in this area in the framework of several other projects.

The video produced jointly by the SNIFFPHONE project partners is available HERE.

  

The SNIFFPHONE project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 644031

March 9th, 2020

Among the authors of an article published in the International Journal of Gastroenterology and Hepatology - leading researcher of the LU KPMI

On February 13 this year, the journal "Systematic review: gastric microbiota in health and disease" was published in the journal "Alimentary Pharmacology & Therapeutics".

Among the authors of the article is M.Leja, Director of the Institute of Clinical and Preventive Medicine.

The article is available in the open-access section of the Wiley Online Library, one of the largest and most authoritative collections of online journals, books, and research resources that encompass life, health, social, and physical sciences.

A summary of the article is available HERE.

March 3rd, 2020

Announced application deadlines for the EHMSG XXXIIInd International Workshop

XXXIIInd International Workshop of the Helicobacter and Microbiota Study Group will take place on September 10 - 12, 2020 in Glasgow, United Kingdom.

Please note the following important dates:

Deadline for Abstract Submission: May 10, 2020
Deadline for Early Bird Registration: July 13, 2020
Deadline Regular Fee: August 16, 2020

More information available HERE.

March 2nd, 2020

Application deadline extended to a seminar on actual ethical and social problems of research biobank governance in the Baltic states 

We kindly invite experts and representatives of research biobanks to attend an international workshop “Ethically and socially responsible governance of research biobanks in the Baltic states” which will take place on March 19, 2020 at the University of Latvia. The aim of the workshop is to exchange experience and discuss actual ethical and social problems of research biobank governance in the Baltic states, as well as to present the results of the project “Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers”, this project is funded by the Latvian Council of Science, project No. lzp-2018/2-01710. The co-organizer of the workshop is BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium).  

All participants are welcome to register to the workshop via email kpmi@lu.lv by March 5, 2020.

Registration is free of charge, on a first-come, first-served basis.

The preliminary programme of the workshop you can find HERE.

The workshop will be part of the annual 78th Scientific Conference of the University of Latvia. 

The work was supported by FLPP (Fundamental and Applied Research Projects) Programm in Latvia, project nr. lzp-2018/2-0171 "Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers"

February 29th, 2020

In Moscow gives a presentation on the best cancer prevention strategy in Europe

In Moscow, Russia, February 27 - 28 the 46th SCIENTIFIC SESSION: "GENETICS IN GASTROENTEROLOGY: POSSIBILITIES AND PERSPECTIVES", organized by the Central Institute for Research on Gastroenterology (ЦНИИГ) took place.

LU KPMI Director M. Leja gave two lectures at the conference on topics of prevention of inherited gastrointestinal tumors and gastric cancer.

In a lecture on stomach cancer, M.Leja talked about:
- GISTAR study in Latvia
- Volatile marker diagnostic projects to detect gastric cancer

Further possibilities for cooperation with leading Russian gastroenterology experts were discussed, incl. opportunities to submit joint projects.

February 26th, 2020

LU Library invites to seminars on scientific publishing

The Library of the University of Latvia invites LU academic, research, and doctoral students to participate in workshops on scientific publishing, retrieval of various scholarly indicators from citation databases (Web of Science, Scopus), and reference management tools (Mendeley, EndNote Online).

More about the topics here.
 
The seminars will take place at the Science House of the University of Latvia, Room 209, Jelgavas Street 3 (the room is equipped with computers). Seats are limited!

You are welcome to apply:

March 4,  16.30-18.00 Introduction to the scientific publication process.
APPLY FOR

March 11, 16.30-18.30 "How to use the databases of Web of Science and Scopus for study and research work?".
APPLY FOR

March 18, 16.30-18.30 Reference Tools: A Handy Solution for Writing, Quoting, and Preparing References.
APPLY FOR

February 17th, 2020

The creation of a Unified Cancer Centre is under discussion in Brussels

The first joint meeting of the EC Cancer Mission Council and the Assembly of this mission took place in Brussels, 14 February, to discuss actions to be taken in the strategic planning documents.

Members of the Assembly, leaders and members of many of the leading European organizations in the field of oncology, had prepared a number of recommendations and additions to the documents produced by the Mission Council.

Activities include many potential issues for Latvia, such as the establishment and accreditation of a national Unified Cancer Center (currently one of the six EU countries where such accreditation does not exist), ensuring the availability of a cancer screening system that meets European quality criteria, etc.

As an unprecedented negative example of the EU, all participants of the meeting were publicly referred to the Latvian-Estonian alcohol tax fight.

February 14th, 2020

Latvia joins network of European infrastructure for translational medicine

From 11 to 12 February, the annual meeting of the EATRIS European infrastructure for translational medicine Course was held in Lisbon, Portugal.

Since the beginning of 2020, Latvia has joined the network as an associate member.

During these two days, was exchange best practices and defined together the role that EATRIS will play in the development of Personalised Medicine. Also were discused how to fully exploit the capacities of the Infrastructure to serve the needs of the patient community and how to develop technologies that will support the implementation of patient-targeted interventions.

In the picture (from left): Latvian delegation - Zaiga Nora-Krūkle, Ilmārs Stonāns, Maija Dambrova, Mārcis Leja

February 7th, 2020

At the conference in St. Petersburg reports on the epidemiology of stomach cancer and screening options

On February 6, a scientific-practical conference on the different aspects of gastric cancer "Stomach Cancer - A to Z" was held at Pavlov First Saint Petersburg State Medical University. The conference was attended by leading oncologists and management from St. Petersburg University, and practitioners from hospitals and outpatient clinics in the region.

The keynote presentation of the conference on the epidemiology and screening capabilities of gastric cancer was given by director of KPMI, professor M.Leja. 

In his lecture, he focused on both the GISTAR project implemented by the International Agency for Research on Cancer and the diagnostic capabilities of volatile markers, including those currently underway in the H2020 VOGAS project.

  

In the picture: M.Leja with the main organizer of the conference, oncology surgeon, Professor Alexander Zakarenko

VOGAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

February 4th, 2020

Brussels opens consultation on Europe cancer plan

On February 4, during the World Cancer Day in Brussels, the European Commissioner for Health formally opened a public consultation on Europe's beating cancer plan in the presence of the EC President.

Details can be found HERE

January 30th, 2020

A working meeting for the VOGAS project takes place in Austria

The annual H2020 VOGAS project working meeting takes place in See, Austria, January 26 - 31. During the meeting project progress and future project plans are discussed.

From KPMI the meeting is represented by Director of the institute prof. Mārcis Leja and PhD student Linda Mežmale.

VOGAS project - "Screening of Gastric Cancer via Breath volatile organic compunds by Hybrid Sensing Approach".

The aim of the VOGAS H2020 project is to clarify the sources of volatile markers, to perform the clinical approbation of the latest generation stationary breath analyzer for early diagnosis of cancer. Using the latest generation of stationary breath analyzers to detect volatile markers, take part in an international stomach cancer screening program to improve this non-invasive method of for diagnosis of cancer.

 

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 

January 28th, 2020

Invites to a seminar on actual ethical and social problems of research biobank governance in the Baltic states as part of the annual Scientific Conference of the University of Latvia

We kindly invite experts and representatives of research biobanks to attend an international workshop “Ethically and socially responsible governance of research biobanks in the Baltic states” which will take place on March 19, 2020 at the University of Latvia. The aim of the workshop is to exchange experience and discuss actual ethical and social problems of research biobank governance in the Baltic states, as well as to present the results of the project “Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers”, this project is funded by the Latvian Council of Science, project No. lzp-2018/2-01710. The co-organizer of the workshop is BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium).  

All participants are welcome to register to the workshop via email kpmi@lu.lv by March 1, 2020. Registration is free of charge, on a first-come, first-served basis.

The preliminary programme of the workshop you can find HERE.

The workshop will be part of the annual 78th Scientific Conference of the University of Latvia. You are also kindly invited to submit an abstract and to participate in the conference on March 20, 2020.

https://www.mf.lu.lv/petnieciba/konferences/international-scientific-conference-on-medicine/

The work was supported by FLPP (Fundamental and Applied Research Projects) Programm in Latvia, project nr. lzp-2018/2-0171 "Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers"

January 27th, 2020

The H2020 project PERSIST is launched with the first consortium meeting at Gradiant headquarters

On January 24, Vigo (Spain)  an international meeting of PERSIST project partners was hosted by the project manager - the Spanish ICT technology center Gradiant in its headquarters. The meeting, which was attended by 40 experts from Europe and Turkey, set out the main aims of the research to learn about the problems commonly encountered by patients who have survived breast and colorectal cancer.
 
This H2020 project will focus on creating an innovative platform to improve care for cancer survivors.
 
All partners came together at the Kick-off Meeting, in order to turn this ambitious project into reality. They all shared their knowledge, experience and plans for the future development of the project. The meeting began with an introduction to the Project PERSIST and active participation from the side of all present stakeholders. The consortium meeting then continued with specific and aspect-oriented presentations and debates. All partners clearly showed their designated role in the project and in what way they can best contribute to it.
 
The variety of experts gathered at the Kick-off Meeting can be perceived as great contribution to all aspects of PERSIST and can add value to the project itself. During the first year, the project will be mainly focused on data gathering, analysis and research. Therefore, ideas and suggestions were actively exchanged throughout the whole consortium meeting. It was made clear that every little detail of the project will be analysed, in order to reach maximum efficiency and be as productive as possible for the benefit of the cancer survivor patients and clinicians.
 
At the closing day of the Kick-off Meeting, all partners on the project parted with clear vision, mission and determination about the future of the project PERSIST. In today’s digital world, the patients are going to rely more and more on digital solutions, in order to overcome the difficulties connected with their treatment. However, the free access to Internet and data poses challenges, which is why our common initiative comes in the right moment, as it provides safe and secure information, coordinated by patients, clinicians and experts.
 
Within the framework of the PERSIST project, Institute of Clinical and Preventive Medicine of the University of Latvia will provide clinical research.
 
More information about the meeting HERE.

The official project information is available HERE.

  

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 87540

January 24th, 2020

New EU Beating Cancer Plan outlined in Brussels Oncology Meeting

A joint meeting of the "Horizon 2020" Programme Committee and Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases is taking place today in the European Commission building in Brussels. During the session was analyzed the survey of resources invested in cancer research by EU Member States, outlined the new EU Beating Cancer Plan and gaved a brief overview of the activities of the EU Cancer Mission. At the meeting Latvia is represented by the Ministry of Health and Education, the National Agency for Education and Development, as well as members of the Program Committee, including director of KPMI M.Leja. 

January 23th, 2020

Invites to apply for train the trainer program  in research ethics and academic integrity

As a consortium partner of H2020 VIRT2UE project providing a methodologically sound and didactically innovative train the trainer program for ethics and research integrity trainers, the Institute of Clinical and Preventive Medicine, University of Latvia is organizing the regional training. The face-to-face training will take place on June15-16 and August 28, 2020 (2+1 days) in Riga, University of Latvia.  
Using a virtue ethics approach to ethics and research integrity, the program aims to foster the internalization of the principles of European Code of Conduct for Research Integrity (ECoC), and thus to facilitate the cultivation of scientific virtues among trainers and researchers. 
The program consists of an online module and three days of face to face training. Further information on its content and structure can be found in a brochure on the Embassy of Good Science available under www.embassy.science/training.  
You can register for the train the trainer programme by sending a filled registration form to the e-mail kpmi@lu.lv by April 1, 2020. 

   

The work was supported by  funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 787580

January 20th, 2020

Within the framework of the H2020 project learns a method for faster, more accessible and easier diagnosis of tuberculosis and other diseases

January 14 - 16, KPMI researchers Ilva Pole, Reinis Vangravs and Ģirts Šķenders visited Munich to learn the ultra-fast polymerase chain reaction method for faster, more accessible and easier diagnosis of tuberculosis and potentially other diseases. The basic principles of the method have been developed at the partner GNA Biosolutions Laboratory, within the framework of Horizon 2020 project "Point-of-Care implementation of TB testing with ultrafast laser PCR" (PITBUL). The task of the Latvian researchers in this project is to improve the principles of clinical specimen preparation for further use in the ultrafast polymerase chain reaction method.

  

The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 768889

January 13th, 2020

9,000 respondents already in GISTAR study!

We are pleased to announce that the total number of respondents included in GISTAR, the largest LU KPMI study, has already reached 9,000!

In its turn, Jekabpils Regional Center has already included 689 respondents.

It is planned to continue the research in Jekabpils till the end of this year.

The GISTAR study in Latvia has been going on for six years.

  

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

January 10th, 2020

One of the initiators of the Million Microbiome of Human Project (MMHP) - LU KPMI

January 6-8, 2020, Shenzhen, China.  The 1st Symposium on Million Microbiome of Human Project (MMHP) took place in the China National GeneBank. This is an ambitious and unique project aiming to draw human microbial maps of different races, ages, genders and health conditions based on at least 1 milj. metagenome analysis.
Involvement of research institutions from all over the world is anticipated. Latvia has been among the initiators of the project. The Director of the Latvian Biomedical Research and Study Centre Jānis Kloviņš and the Director of Institute of Clinical and Preventive Medicine Mārcis Leja were representing our country in the conference. They were presenting the research performed in this field in Latvia so far.
MMHP is supported by the internationally leading experts in molecular biology – the BGI Company. Their daughter company MGI is also established in Latvia.

January 7th, 2020

PERSIST : AI and Big Data available to healthcare 

Lead by Gradiant, Spanish ICT technology center in collaboration with the University of Latvia and eleven other partners, PERSIST is starting in January 2020. 

The PERSIST project ("Patients-centered SurvivorShip care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies") will combine the expertise of its partners to develop an innovative platform that will support the decision-making of medical doctors to improve the care of cancer survivors.

13 entities from 10 countries participate in this international research based on Artificial Intelligence and Big Data for the health industry.

The consortium, with partners from Spain, Italy, Austria, Bulgaria, Slovenia, Latvia, Switzerland, Portugal, Belgium and Turkey, is funded by the European Union with more than 5 million euros, under the Horizon 2020 program. 

Within the framework of the PERSIST project, Institute of Clinical and Preventive Medicine of the University of Latvia will provide clinical research.

More information about the PERSIST project see HERE.

   

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

January 6th, 2020

Visits China National Gene Bank

Marcis Leja, Director of KPMI, together with Janis Klovins, Director of the Latvian Biomedical Research and Study Center / BBMRI Latvian Organization, visits to the CNGB - the China National Gene Bank.

08.01.2020. Shenzhen (China). Wang Jian, the president and founder of BGI, demonstrates sequencing automation capabilities at China's National Biobank.

 

Copyright 2016 - 2020 by LU KPMI